A detailed history of Engineers Gate Manager LP transactions in Codexis, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 154,968 shares of CDXS stock, worth $447,857. This represents 0.01% of its overall portfolio holdings.

Number of Shares
154,968
Previous 211,267 26.65%
Holding current value
$447,857
Previous $644,000 16.15%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.59 - $4.65 $145,814 - $261,790
-56,299 Reduced 26.65%
154,968 $540,000
Q4 2023

Feb 14, 2024

BUY
$1.54 - $3.37 $15,549 - $34,026
10,097 Added 5.02%
211,267 $644,000
Q3 2023

Nov 14, 2023

SELL
$1.5 - $3.75 $93,699 - $234,247
-62,466 Reduced 23.69%
201,170 $380,000
Q2 2023

Aug 14, 2023

BUY
$2.21 - $4.43 $206,394 - $413,722
93,391 Added 54.86%
263,636 $738,000
Q1 2023

May 15, 2023

BUY
$3.81 - $6.76 $89,512 - $158,819
23,494 Added 16.01%
170,245 $704,000
Q4 2022

Feb 14, 2023

BUY
$4.26 - $6.84 $130,049 - $208,811
30,528 Added 26.27%
146,751 $683,000
Q3 2022

Nov 14, 2022

SELL
$6.06 - $12.86 $1.12 Million - $2.37 Million
-184,436 Reduced 61.34%
116,223 $704,000
Q2 2022

Aug 15, 2022

BUY
$8.35 - $21.89 $2.24 Million - $5.88 Million
268,405 Added 832.16%
300,659 $3.15 Million
Q1 2022

May 16, 2022

BUY
$16.97 - $31.93 $547,350 - $1.03 Million
32,254 New
32,254 $665,000
Q4 2021

Feb 14, 2022

SELL
$25.61 - $41.78 $332,622 - $542,638
-12,988 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$19.65 - $27.99 $255,214 - $363,534
12,988 New
12,988 $302,000
Q4 2020

Feb 16, 2021

SELL
$11.7 - $23.41 $199,999 - $400,170
-17,094 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$11.21 - $13.82 $84,770 - $104,506
-7,562 Reduced 30.67%
17,094 $201,000
Q2 2020

Aug 17, 2020

BUY
$9.8 - $12.77 $241,628 - $314,857
24,656 New
24,656 $281,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $189M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.